Erasca, Inc. Variable Lease, Cost
Erasca, Inc. (ERAS) reported Variable Lease, Cost of $1.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-11
- Erasca, Inc. variable lease, cost for the quarter ending 2026-06-30 was $1.07M, a 4.00% increase year-over-year.
- Erasca, Inc. variable lease, cost for the quarter ending 2026-03-31 was $751.00K, a 34.30% decline year-over-year.
- Erasca, Inc. variable lease, cost for the quarter ending 2025-12-31 was $1.03M, a 10.43% increase year-over-year.
- Erasca, Inc. variable lease, cost for the quarter ending 2025-09-30 was $1.03M, a 9.15% increase year-over-year.
- Erasca, Inc. variable lease, cost for fiscal 2025 was $4.22M, a 14.01% increase from fiscal 2024.
- Erasca, Inc. variable lease, cost for fiscal 2024 was $3.70M, a 0.72% decline from fiscal 2023.
- Erasca, Inc. variable lease, cost for fiscal 2023 was $3.73M, a 107.28% increase from fiscal 2022.
- Erasca, Inc. variable lease, cost for fiscal 2022 was $1.80M, a 319.58% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-11 | $1.82M 10-Q · filed 2026-08-11 | $2.85M derived: sum of 3 quarters · filed 2026-08-11 | $3.87M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $751.00K 10-Q · filed 2026-05-11 | $1.78M derived: sum of 2 quarters · filed 2026-05-11 | $2.80M derived: sum of 3 quarters · filed 2026-05-11 | $3.83M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.05M derived: sum of 2 quarters · filed 2026-03-12 | $3.08M derived: sum of 3 quarters · filed 2026-08-11 | $4.22M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $1.03M 10-Q · filed 2025-11-12 | $2.05M derived: sum of 2 quarters · filed 2026-08-11 | $3.20M 10-Q · filed 2025-11-12 | $4.13M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $1.03M 10-Q · filed 2026-08-11 | $2.17M 10-Q · filed 2026-08-11 | $3.10M derived: sum of 3 quarters · filed 2026-08-11 | $4.04M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $1.14M 10-Q · filed 2026-05-11 | $2.07M derived: sum of 2 quarters · filed 2026-05-11 | $3.01M derived: sum of 3 quarters · filed 2026-05-11 | $3.93M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.87M derived: sum of 2 quarters · filed 2026-03-12 | $2.79M derived: sum of 3 quarters · filed 2026-03-12 | $3.70M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $940.00K 10-Q · filed 2025-11-12 | $1.86M derived: sum of 2 quarters · filed 2025-11-12 | $2.77M 10-Q · filed 2025-11-12 | $2.80M 10-Q · filed 2024-11-12 | $3.60M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $918.00K 10-Q · filed 2025-08-12 | $1.83M 10-Q · filed 2025-08-12 | $1.80M 10-Q · filed 2024-08-12 | $2.67M derived: sum of 3 quarters · filed 2025-08-12 | $3.52M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $916.00K 10-Q · filed 2025-05-13 | $1.75M derived: sum of 2 quarters · filed 2025-05-13 | $2.61M derived: sum of 3 quarters · filed 2025-05-13 | $3.46M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.69M derived: sum of 2 quarters · filed 2025-03-20 | $2.55M derived: sum of 3 quarters · filed 2025-03-20 | $3.73M 10-K · filed 2025-03-20 | $3.70M 10-K · filed 2024-03-27 | ||
| 2023-09-30 | $859.00K 10-Q · filed 2024-11-12 | $1.72M derived: sum of 2 quarters · filed 2024-11-12 | $2.90M 10-Q · filed 2024-11-12 | $3.62M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $859.00K 10-Q · filed 2024-08-12 | $2.00M 10-Q · filed 2024-08-12 | $2.76M derived: sum of 3 quarters · filed 2024-08-12 | $3.46M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-08 | $1.90M derived: sum of 2 quarters · filed 2024-05-08 | $2.60M derived: sum of 3 quarters · filed 2024-05-08 | $2.88M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.40M derived: sum of 2 quarters · filed 2024-03-27 | $1.68M derived: sum of 3 quarters · filed 2024-03-27 | $1.80M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $701.00K 10-Q · filed 2023-11-09 | $979.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.10M 10-Q · filed 2023-11-09 | $1.20M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $278.00K 10-Q · filed 2023-08-10 | $396.00K 10-Q · filed 2023-08-10 | $500.00K derived: sum of 3 quarters · filed 2023-08-10 | $596.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $117.00K 10-Q · filed 2023-05-15 | $222.00K derived: sum of 2 quarters · filed 2023-05-15 | $318.00K derived: sum of 3 quarters · filed 2023-05-15 | $441.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $201.00K derived: sum of 2 quarters · filed 2023-03-23 | $324.00K derived: sum of 3 quarters · filed 2023-03-23 | $429.00K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $96.00K 10-Q · filed 2022-11-09 | $219.00K derived: sum of 2 quarters · filed 2022-11-09 | $324.00K 10-Q · filed 2022-11-09 | $410.00K derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $123.00K 10-Q · filed 2022-08-11 | $228.00K 10-Q · filed 2022-08-11 | $314.00K derived: sum of 3 quarters · filed 2022-08-11 | $408.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $105.00K 10-Q · filed 2022-05-12 | $191.00K derived: sum of 2 quarters · filed 2022-05-12 | $285.00K derived: sum of 3 quarters · filed 2022-05-12 | $363.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $180.00K derived: sum of 2 quarters · filed 2022-03-24 | $258.00K derived: sum of 3 quarters · filed 2022-03-24 | $355.00K 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $94.00K 10-Q · filed 2021-11-10 | $172.00K derived: sum of 2 quarters · filed 2021-11-10 | $269.00K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $78.00K 10-Q · filed 2021-08-26 | $175.00K 10-Q · filed 2021-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |